About

OAIP OceanCourse Description

The contemporary management of heart failure is characterized by evolving strategies to combine newer approaches based on research advances with well established evidence-based standards of care. This educational activity is designed to provide a comprehensive overview of the current strategies for the treatment of heart failure. Course faculty will review cutting-edge approaches to diagnosis and classification and provide techniques and tips for the pharmacological and device management of heart failure. The material presented will have an interdisciplinary focus and will be of interest to physicians and other health care professionals who care for patients with heart failure.

Officially Endorsed by HFSA!

Officially Endorsed by the Heart Failure Society of America. The opinions presented in this educational activity fo not necessarily reflect the opinions or recommendations of the HFSA.

Learning Objectives

The information presented at this evidence-based activity should improve your ability to:

  • Discuss the clinical profile of heart failure and differentiate between reduced and preserved ejection fraction patients
  • Apply appropriate strategies to optimize pharmacologic treatment of heart failure
  • Utilize medical devices, surgical therapies and biomarker assessment in the care of heart failure patients
  • Outline management of important co-morbid conditions in heart failure
  • Discuss future directions in the management of heart failure

Target Audience

This course is designed for Cardiologists, Family Medicine Physicians, General Internists, Nurses and Nurse Practitioners, Physician Assistants, Pharmacists, Hospitalists and Cardiology Technicians.

Educational Format

Course faculty will present information in a case discussion and lecture format. There will be opportunities for the audience to ask questions in a panel discussion setting.

Faculty Disclosure

University of Florida College of Medicine adheres to the ACCME Standards regarding commercial support of continuing medical education. It is policy that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this education activity, that relevant conflicts of interest are resolved, and that speakers will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure will be made in the course syllabus.